M. Wick
- Immunology top 10%
- Immunotherapy and Immune Responses 2
-
- Protease and Inhibitor Mechanisms 2
- Immunology and Allergy top 10%
- Oncology top 10%
- CAR-T cell therapy research 2
- Cancer-related Molecular Pathways 2
-
- Ubiquitin and proteasome pathways 2
- Nuclear Structure and Function 1
-
- Telomeres, Telomerase, and Senescence 2
-
- Nuclear Receptors and Signaling 2
- Co-authors
- Rolf MüllerGretchen HagenChristiane BürgerSabine BrüsselbachFrances C. LucibelloHans SchreiberClaudia BürgerHartmut Koeppen
- Partner nations
- GermanyUnited States
In The Last Decade
M. Wick
12 papers receiving 831 citations
Peers
Comparison fields: 5 of 81
- Immunology 234
- Cancer Research 159
- Immunology and Allergy 64
- Oncology 243
- Aging 15
Countries citing papers authored by M. Wick
This map shows the geographic impact of M. Wick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Wick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Wick more than expected).
Fields of papers citing papers by M. Wick
This network shows the impact of papers produced by M. Wick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Wick. The network helps show where M. Wick may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M. Wick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | TLK286-induced activation of the stress response apoptotic signaling pathway | 2002 | 6 |
| 2 | 1999 | 229 | |
| 3 | 1997 | 163 | |
| 4 | Transgenic human DAF-expressing porcine livers: their function during hemoperfusion with human blood. | 1996 | 3 |
| 5 | 1996 | 35 | |
| 6 | 1995 | 56 | |
| 7 | 1995 | 54 | |
| 8 | 1994 | 40 | |
| 9 | 1994 | 66 | |
| 10 | 1994 | 109 | |
| 11 | 1994 | 71 | |
| 12 | Inhibition of Fos- and Ras-induced transformation by mutant Fos proteins with structural alterations in functionally different domains. | 1992 | 25 |
About M. Wick
M. Wick is a scholar working on Immunology, Oncology and Cancer Research, having authored 12 papers that have together received 857 indexed citations. Recurring topics across this work include CAR-T cell therapy research (2 papers), Ubiquitin and proteasome pathways (2 papers), Immunotherapy and Immune Responses (2 papers), Protease and Inhibitor Mechanisms (2 papers), Cancer-related Molecular Pathways (2 papers), Telomeres, Telomerase, and Senescence (2 papers), Nuclear Receptors and Signaling (2 papers) and Nuclear Structure and Function (1 paper). The work is most often cited by research in Immunology (234 citations), Cancer Research (159 citations) and Immunology and Allergy (64 citations). M. Wick has collaborated with scholars based in Germany and United States. Frequent co-authors include Rolf Müller, Gretchen Hagen, Christiane Bürger, Sabine Brüsselbach, Frances C. Lucibello, Hans Schreiber, Claudia Bürger, Hartmut Koeppen, Jeffrey A. Bluestone and Patrick E. Fields. Their work appears in journals such as Journal of Cell Science, Gene, Biochemical Journal, Experimental Cell Research and Seminars in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.